HIV-1 Infection

Showing 1 - 25 of 178

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases

Not yet recruiting
  • Multi-Drug Resistant Hiv-1 Infection
  • HIV-1 Infection
  • UB-421
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

HIV-1 Infection Trial (DOR/ISL, BIC/FTC/TAF, Placebo to DOR/ISL)

Not yet recruiting
  • HIV-1 Infection
  • (no location specified)
Jan 20, 2023

HIV-1 Infection Trial in Worldwide (ISL, DOR, DOR/ISL)

Active, not recruiting
  • HIV-1 Infection
  • Birmingham, Alabama
  • +97 more
Jan 5, 2023

HIV-1 Infection Trial (ART, DOR/ISL)

Not yet recruiting
  • HIV-1 Infection
  • (no location specified)
Jan 4, 2023

HIV-1 Infection Trial (DOR/ISL, BIC/FTC/TAF, Placebo to BIC/FTC/TAF)

Not yet recruiting
  • HIV-1 Infection
  • (no location specified)
Dec 19, 2022

PREPARE (A5361s) Substudy of REPRIEVE (A5332)

Active, not recruiting
  • HIV-1 Infection
  • Birmingham, Alabama
  • +32 more
Dec 7, 2022

HIV-1 Infection Trial in Worldwide (DOR/ISL, BIC/FTC/TAF, Placebo to BIC/FTC/TAF)

Active, not recruiting
  • HIV-1 Infection
  • Birmingham, Alabama
  • +94 more
Nov 28, 2022

HIV-1 Infection Trial in United States (Oral Lenacapavir, Subcutaneous Lenacapavir, Teropavimab)

Active, not recruiting
  • HIV-1 Infection
  • Oral Lenacapavir
  • +3 more
  • Los Angeles, California
  • +22 more
Nov 4, 2022

HIV-1 Infection Trial in Worldwide (DOR/ISL)

Active, not recruiting
  • HIV-1 Infection
  • Washington, District of Columbia
  • +16 more
Oct 13, 2022

HIV-1 Infection Trial (Doravirine, Tenofovir, Lamivudine, Baseline regimen of ritonavir- or cobicistat-boosted protease

Active, not recruiting
  • HIV-1 Infection
  • Doravirine, Tenofovir, Lamivudine
  • +4 more
  • (no location specified)
Sep 2, 2022

HIV-1 Infection Trial in Kaohsiung City, Taiwan (UB-421, chidamide)

Recruiting
  • HIV-1 Infection
  • Kaohsiung City, Taiwan, Taiwan
    Kaohsiung Veterans General Hospital
Aug 25, 2022

HIV-1 Infection Trial in Israel, South Africa, United States (Islatravir, Placebo)

Active, not recruiting
  • HIV-1 Infection
  • Hollywood, Florida
  • +8 more
Aug 24, 2022

HIV-1 Infection Trial in Worldwide (MK-8591A)

Recruiting
  • HIV-1 Infection
  • Phoenix, Arizona
  • +87 more
Aug 18, 2022

HIV-1 Infection Trial (MK-8507)

Completed
  • HIV-1 Infection
  • (no location specified)
Jul 22, 2022

HIV-1 Infection Trial in United States (ISL, LEN, B/F/TAF)

Active, not recruiting
  • HIV-1 Infection
  • Los Angeles, California
  • +23 more
Jul 12, 2022

HIV-1 Infection Trial in Kaohsiung City (UB-421 SC(dB4C7C22-6 mAb))

Recruiting
  • HIV-1 Infection
  • UB-421 SC(dB4C7C22-6 mAb)
  • Kaohsiung City, Taiwan
    Kaohsiung Veterans General Hospital
May 12, 2022

HIV-1 Infection Trial in Worldwide (Islatravir, Placebo to Islatravir, Doravirine)

Completed
  • HIV-1 Infection
  • Phoenix, Arizona
  • +25 more
Mar 31, 2022

HIV-1 Infection Trial in Caba, Rosario (Dolutegravir plus lamivudine)

Withdrawn
  • HIV-1 Infection
  • Dolutegravir plus lamivudine
  • Caba, Buenos Aires, Argentina
  • +1 more
Apr 5, 2022

HIV-1 Infection Trial in Worldwide (DTG, F/TAF, B/F/TAF)

Completed
  • HIV-1 Infection
  • Phoenix, Arizona
  • +124 more
Feb 10, 2022

HIV-1 Infection Trial in Worldwide (ABC/DTG/3TC, B/F/TAF, ABC/DTG/3TC Placebo)

Completed
  • HIV-1 Infection
  • Birmingham, Alabama
  • +120 more
Feb 7, 2022

HIV-1 Infection Trial in Worldwide (elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or

Active, not recruiting
  • HIV-1 Infection
  • elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide or bictegravir/emtricitabine/tenofovir alafenamide or other medically-appropriate FDA-approved antiretroviral therapy
  • Birmingham, Alabama
  • +29 more
Jan 24, 2022

HIV-1 Infection Trial in Toulouse (Peripheral blood and intestinal biopsies will be collected)

Completed
  • HIV-1 Infection
  • Peripheral blood and intestinal biopsies will be collected
  • Toulouse, France
  • +1 more
Dec 30, 2021

HIV-1 Infection Trial in France (Samplings)

Recruiting
  • HIV-1 Infection
  • Samplings
  • Clamart, France
  • +6 more
Jan 4, 2022

HIV-1 Infection Trial in All The Regions Of The Country (40 Centers) (Dolutegravir, Darunavir-cobicistat,

Completed
  • HIV-1 Infection
  • All The Regions Of The Country (40 Centers), France
    (unnamed)
Jan 3, 2022

HIV-1 Infection Trial in Beijing (SHR2150;Placebo)

Completed
  • HIV-1 Infection
  • SHR2150;Placebo
  • Beijing, Beijing, China
    Beijing youan Hospital,Capital medical university
Dec 24, 2021